|Bid||127.90 x 100|
|Ask||127.92 x 200|
|Day's range||127.09 - 128.26|
|52-week range||121.35 - 148.32|
|PE ratio (TTM)||269.09|
|Earnings date||17 Jul 2018|
|Forward dividend & yield||3.36 (2.57%)|
|1y target est||149.05|
The major equity indexes barely moved today, as a postearnings drop from International Business Machines (IBM) was canceled out by gains from Textron (TXT), Intuitive Surgical (ISRG), and others. Ultimately, it shows once again that it's as much a market of stocks as it is a stock market. The Dow Jones Industrial Average dropped 38.56 points, or 0.2%, to 24,748.07, while the S&P 500 ticked up 0.1% to 2708.64, and the Nasdaq Composite advanced 0.2% to 7295.24.
The Dow Jones Industrial Average on Wednesday morning was wrestling with sharp declines in IBM and Johnson & Johnson. Shares of International Business Machines Corp. were off 7.2%, or about $11.50, which equates to a drop of about 80 points, while J&J's stock was contributing a further 24-point retreat in the benchmark, down 2.7%, or about $3.50, in recent action. Overall, the Dow was still managing to rise by about 24 points, or less than 0.1%, at 24,802, with J&J and IBM's tumble slightly offset by gains in Home Depot Inc. Caterpillar Inc. and Boeing Co. 's stocks.
Trade, taxes and China are the main themes to watch for heading into first-quarter earnings, along with a spate of potential deals.
Stocks that moved substantially or traded heavily Tuesday: UnitedHealth Group Inc., up $8.23 to $238.55 The health insurer raised its annual profit forecast after a strong first quarter. Tesla Inc., down ...
Johnson & Johnson nudged its 2018 sales guidance higher Tuesday as demand for cancer drugs surged in the first quarter, even as its blockbuster Remicade continued to face competitive pressure.
Analysts expect Novartis’s (NVS) revenue to rise ~8.8% to $12.6 billion in 1Q18 following growth in operating revenues across all three of its segments during the quarter.
Much-higher spending and one-time charges offset a12.6 percent jump in health care giant Johnson & Johnson's first-quarter revenue, trimming its profit by 1.2 percent, but the results still beat Wall Street ...
Strength in Q1 earnings season, at least in these early stages, has helped bolster market indexes. This continues ahead of Tuesday's market open.
J&J (JNJ) beats estimates for both earnings and sales in the first quarter of 2018. It maintains the previously issued earnings guidance for 2018 while increasing the sales range.
The Dow Jones Industrial Average could open up more than 200 points this morning as investors celebrate solid earnings from the likes of Goldman Sachs (GS), UnitedHealth (UNH) and Johnson & Johnson (JNJ). S&P 500 futures have advanced 0.6%, while Dow Jones Industrial Average futures have gained 200 points, or 0.8%. As we mentioned earlier this morning, the big debate heading into earnings season was whether earnings would be good enough to boost the market.
Yahoo Finance's LIVE market coverage and analysis of what you need to watch in the stock market begins each day at 9:25 a.m. ET.
Blue chip names stepped up to help Netflix drive premarket trading Tuesday, as the market's uptrend aimed to break past resistance.
US stock-index futures are pointing higher on Tuesday as investors draw encouragement from the gathering pace of corporate earnings. S&P 500 futures are up 0.6 per cent this morning, while those for the ...
J&J (JNJ) beat estimates for both earnings and sales in the first quarter of 2018. It maintained the previously issued earnings guidance for 2018 while increasing the sales range.
Dominic Caruso, chief financial officer at Johnson & Johnson, discusses the company's earnings, outlook and deployment of capital. He speaks with David Westin on "Bloomberg Daybreak: Americas." ...
Global stocks turned higher on Tuesday after upbeat U.S. corporate earnings reports and robust Chinese economic growth data. KEEPING SCORE: France's CAC 40 was up 0.4 percent to 5,333, while Germany's ...
NEW YORK, April 17, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...
Johnson & Johnson posted quarterly sales and profits that were ahead of Wall Street expectations, sending shares in the healthcare company higher in premarket trading. The world’s largest healthcare company ...